A detailed history of Cibc Bancorp Usa Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 4,293,331 shares of ABT stock, worth $558 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
4,293,331
Holding current value
$558 Million
% of portfolio
0.71%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025

SELL
$120.51 - $136.62 $487 Million - $552 Million
-4,038,426 Reduced 94.06%
254,905 $34.1 Million
Q3 2025

Nov 12, 2025

BUY
$120.51 - $136.62 $517 Million - $587 Million
4,293,331 New
4,293,331 $575 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.